OncoPep
After graduating with a Bachelor of Science from the University of Florida, Jen began her biotech career in 2002. For more than 10 years, she trained and worked within multiple disciplines both QC and QA based, several of those years in management level positions. In 2015, Jen transitioned into a QA consulting role, became a certified auditor and has a diverse portfolio of QMS building experience.
This person is not in any offices
OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.